logo
Plus   Neg
Share
Email

Ironwood, Bionomics Collaborate On Anti-Anxiety Compound BNC210 - Quick Facts

Ironwood Pharmaceuticals Inc. (IRWD) and Australia-based Bionomics Limited Wednesday entered into a collaboration, research, and licensing agreement that will enable Ironwood to develop and commercialize Bionomics' investigational anti-anxiety compound BNC210 and other related compounds.

According to the companies, the aim of collaboration is to assess the compound's potential as a novel anti-anxiety treatment. Data from several preclinical studies indicate that BNC210 has anti-anxiety activity without the sedative side effects that are typical of benzodiazepines, a class of drugs used to treat anxiety, they said.

As per the terms, the companies will collaborate on initial research, and Massachusetts-based Ironwood will be responsible for worldwide development and commercialization of all products incorporating BNC210 or other licensed compounds, including funding of clinical trials.

The companies said that pending achievement of certain development and regulatory milestones, Bionomics could receive up to US$345 million in upfront and milestone payments and research funding, as well as royalties on sales of products incorporating BNC210 and other related compounds.

Over the next 24 months, Bionomics may receive up to US$13 million in research funding and milestone payments, including an initial payment of US$3 million.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Harley-Davidson Inc. (HOG) disclosed in a regulatory filing that it will be implementing a plan to shift production of motorcycles for the European Union destinations from the U.S. to its international facilities to avoid European Union's tariff. The company expects ramping-up production in international... Want to know when you will die? Google can tell. Google has tested an artificial intelligence or AI computer system that can predict whether hospital patients will pass away 24 hours after admission. Not just that, the system can also guess the length of a patient's stay in hospital and his chances of being readmitted. Piper Jaffray analyst Michael Olson said Monday that the video-game industry revenue could be 100 percent digital by 2022 and result in publisher margins being "dramatically higher." According to Olson, an all-digital video game world would be a tailwind for publishers like Activision Blizzard Inc., Electronic Arts Inc. and Take-Two Interactive Inc.
Follow RTT